Nyxoah SA (NYXH)
7.95
0.00 (0.00%)
USD |
NASDAQ |
Jun 25, 16:00
7.95
0.00 (0.00%)
After-Hours: 20:00
Nyxoah Enterprise Value: 189.86M for June 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 24, 2024 | 189.86M |
| June 21, 2024 | 205.93M |
| June 20, 2024 | 225.72M |
| June 18, 2024 | 200.76M |
| June 17, 2024 | 206.79M |
| June 14, 2024 | 183.27M |
| June 13, 2024 | 192.16M |
| June 12, 2024 | 192.73M |
| June 11, 2024 | 204.78M |
| June 10, 2024 | 213.67M |
| June 07, 2024 | 212.52M |
| June 06, 2024 | 219.41M |
| June 05, 2024 | 229.16M |
| June 04, 2024 | 212.52M |
| June 03, 2024 | 208.51M |
| May 31, 2024 | 231.74M |
| May 30, 2024 | 224.86M |
| May 29, 2024 | 210.80M |
| May 28, 2024 | 207.07M |
| May 24, 2024 | 205.64M |
| May 23, 2024 | 200.76M |
| May 22, 2024 | 252.10M |
| May 21, 2024 | 248.66M |
| May 20, 2024 | 248.66M |
| May 17, 2024 | 251.53M |
| Date | Value |
|---|---|
| May 16, 2024 | 261.00M |
| May 15, 2024 | 256.41M |
| May 14, 2024 | 236.62M |
| May 13, 2024 | 215.68M |
| May 10, 2024 | 197.89M |
| May 09, 2024 | 206.21M |
| May 08, 2024 | 228.30M |
| May 07, 2024 | 220.84M |
| May 06, 2024 | 220.84M |
| May 03, 2024 | 241.78M |
| May 02, 2024 | 246.65M |
| May 01, 2024 | 233.75M |
| April 30, 2024 | 258.56M |
| April 29, 2024 | 279.35M |
| April 26, 2024 | 266.45M |
| April 25, 2024 | 285.66M |
| April 24, 2024 | 266.30M |
| April 23, 2024 | 262.43M |
| April 22, 2024 | 265.87M |
| April 19, 2024 | 270.17M |
| April 18, 2024 | 260.14M |
| April 17, 2024 | 235.76M |
| April 16, 2024 | 228.58M |
| April 15, 2024 | 217.11M |
| April 12, 2024 | 220.27M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
19.20M
Minimum
Dec 05 2022
857.31M
Maximum
Aug 06 2021
254.33M
Average
154.76M
Median
Sep 07 2023
Enterprise Value Benchmarks
| Galapagos NV | -2.119B |
| UCB SA | 30.24B |
| Mithra Pharmaceuticals SA | -- |
| Celyad Oncology SA | -- |
| MDxHealth SA | 91.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.93M |
| Revenue (Quarterly) | 1.326M |
| Total Expenses (Quarterly) | 14.59M |
| EPS Diluted (Quarterly) | -0.4508 |
| Gross Profit Margin (Quarterly) | 62.74% |
| Profit Margin (Quarterly) | -975.1% |
| Earnings Yield | -20.58% |
| Normalized Earnings Yield | -20.41 |